Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Apyx Medical Corp
(NQ:
APYX
)
1.340
-0.070 (-4.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Apyx Medical Corp
< Previous
1
2
3
4
Next >
APYX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Apyx Medical Corporation
June 07, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
APYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm
June 06, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors
June 06, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
APYX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Apyx Medical Corporation
June 06, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures
May 26, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June
May 25, 2022
From
Apyx Medical Corporation
Via
Business Wire
NASDAQ:APYX Investor Notice: Investigation over Possible Securities Laws Violations by Apyx Medical Corporation
May 13, 2022
San Diego, CA -- (SBWIRE) -- 05/13/2022 -- Apyx Medical Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements.
Via
SBWire
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
May 12, 2022
From
Apyx Medical Corporation
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
April 25, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
April 23, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
April 22, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
APYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corp. on Behalf of Apyx Stockholders and Encourages Investors to Contact the Firm
April 21, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
April 21, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
April 20, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
April 14, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
April 04, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin
April 04, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook
March 17, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Notified of Pending FDA Medical Device Safety Communication Related to its Advanced Energy Products
March 14, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures
February 17, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022
January 27, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results
January 10, 2022
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
November 11, 2021
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December
November 10, 2021
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2021 Financial Results on November 11, 2021
October 04, 2021
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference
September 01, 2021
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company’s Board of Directors
August 30, 2021
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
August 12, 2021
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
July 12, 2021
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
June 03, 2021
From
Apyx Medical Corporation
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.